Non-invasive Brain Stimulation for Treating Symptomatic Convergence Insufficiency — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Non-invasive Brain Stimulation for Treating Symptomatic Convergence Insufficiency — Stella

Recruiting

Back to Convergence Insufficiency trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

Midwestern University Eye Institute, Downers Grove, Illinois

Key details

Sponsor

Midwestern University

Enrollment target

~150 participants

Started

March 2025

Primary completion

December 2028

Age range

18 Years – 40 Years

Last updated December 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov